Nam‐Sun Cho
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nam‐Sun Cho has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
A Hyun Lim
Blood Transfusion Research Institute, Korean Red Cross, Seoul, Korea
1 shared publicationJ. Park
Blood Transfusion Research Institute, Korean Red Cross, Seoul 110-747, Korea
1 shared publicationJi Young Park
Blood Transfusion Research Institute, Korean Red Cross, Seoul, Korea
1 shared publicationO.‐J. Kwon
College of Animal Bioscience & Technology, Konkuk University, Seoul, Korea
1 shared publicationS.‐A. Hong
BioSewoom Institute of Bioscience and Biotechnology, Seoul, Korea
1 shared publicationSeung Hee Han
Seoul Dongbu Blood Center, Korean Red Cross, Seoul, Korea
1 shared publication
Latest Publications
- 21 August 2008
- Published by Wiley in Journal of Medical Virology
- Vol. 80 (10) , 1864-1867
Seroprevalence of human T‐lymphotropic virus type 1 and 2 in Korean blood donors
The seroprevalence rate of human T-lymphotropic virus (HTLV) among the Korean blood donor population was studied to determine whether screening for HTLV should be implemented. A total of 15,173 serum samples collected from June to July 2006 at five Blood Centers which are located closely to Japan geographically, where the prevalence of HTLV is known to be high, were tested. Serological screening was done by a chemiluminescence method. Samples reactive repeatedly on serological screening were confirmed further by Western blot, line immunoassay, nested polymerase chain reaction and sequencing of proviral DNA. Six samples tested reactive with the serological assay showing a reactive rate of 0.004%. Among the six samples, one sample was confirmed as HTLV-1 positive, giving a confirmed reactive rate of 0.007%. Based on the results of this study, an extended study will be conducted to evaluate whether introduction of HTLV screening is necessary in Korea. J. Med. Virol. 80:1864–1867, 2008.
- 21 August 2008
- Published by Wiley in Journal of Medical Virology
- Vol. 80 (10) , 1864-1867
Seroprevalence of human T‐lymphotropic virus type 1 and 2 in Korean blood donors
The seroprevalence rate of human T-lymphotropic virus (HTLV) among the Korean blood donor population was studied to determine whether screening for HTLV should be implemented. A total of 15,173 serum samples collected from June to July 2006 at five Blood Centers which are located closely to Japan geographically, where the prevalence of HTLV is known to be high, were tested. Serological screening was done by a chemiluminescence method. Samples reactive repeatedly on serological screening were confirmed further by Western blot, line immunoassay, nested polymerase chain reaction and sequencing of proviral DNA. Six samples tested reactive with the serological assay showing a reactive rate of 0.004%. Among the six samples, one sample was confirmed as HTLV-1 positive, giving a confirmed reactive rate of 0.007%. Based on the results of this study, an extended study will be conducted to evaluate whether introduction of HTLV screening is necessary in Korea. J. Med. Virol. 80:1864–1867, 2008.
- 11 June 2007
- Published by Wiley in Tissue Antigens
- Vol. 70 (2) , 170-171
Identification of a novel HLA‐B*40 allele, HLA‐B*4071, by sequence‐based typing
HLA‐B*4071 allele shows six nucleotides difference from B*4005 allele in exon 3 at nucleotides 419A>T, 420C>A, 463C>A, 477C>G, 486G>C and 527A>T, resulting in three amino acid changes Tyr116Leu, Arg131Ser and Glu152Val.
- 11 June 2007
- Published by Wiley in Tissue Antigens
- Vol. 70 (2) , 170-171
Identification of a novel HLA‐B*40 allele, HLA‐B*4071, by sequence‐based typing
HLA‐B*4071 allele shows six nucleotides difference from B*4005 allele in exon 3 at nucleotides 419A>T, 420C>A, 463C>A, 477C>G, 486G>C and 527A>T, resulting in three amino acid changes Tyr116Leu, Arg131Ser and Glu152Val.